- You are here:
-
Home
- News
News
- Details
- Category: POZ.com
The European Medicines Agency gave the green light to injectable cabotegravir and rilpivirine for HIV treatment.
- Details
- Category: POZ.com
If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”
- Details
- Category: POZ.com
If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”
- Details
- Category: POZ.com
This finding comes from a small focus group of mothers living with HIV in Canada, most of them born in low-income nations.
- Details
- Category: POZ.com
This finding among sub-Saharan Africans is quite concerning since dolutegravir is now the preferred first-line HIV treatment worldwide.
- Details
- Category: POZ.com
ViiV Healthcare teams with stock photography provider Shutterstock to offer a stigma-busting gallery of images.
- Details
- Category: POZ.com
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
- Details
- Category: POZ.com
The 90-90-90 HIV targets expire at the end of 2020. Bob Leahy looks at what comes next and what role people living with HIV can play.
- Details
- Category: POZ.com
While receiving a lifetime achievement award, the infectious disease expert shares memories and insights.
- Details
- Category: POZ.com
UNAIDS hopes nations will follow the lead of a number of sub-Saharan African countries that are gaining control of their HIV epidemics.
Subcategories
Fundraisers Article Count: 2
Health Article Count: 4
HIV / AIDS Article Count: 4
Partners Article Count: 348
POZ.com Article Count: 347
POZ Stories Article Count: 43
Page 5 of 30
- You are here:
-
Home
- News